Ryan Gerbrandt - Anterix Chief Officer
| ATEX Stock | USD 31.31 0.31 0.98% |
Insider
Ryan Gerbrandt is Chief Officer of Anterix
| Age | 45 |
| Address | 3 Garret Mountain Plaza, Woodland Park, NJ, United States, 07424 |
| Phone | 973 771 0300 |
| Web | https://www.anterix.com |
Anterix Management Efficiency
The company has return on total asset (ROA) of (0.1153) % which means that it has lost $0.1153 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0955 %, meaning that it created $0.0955 on every $100 dollars invested by stockholders. Anterix's management efficiency ratios could be used to measure how well Anterix manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.2 in 2024. Return On Capital Employed is likely to drop to -0.21 in 2024. At this time, Anterix's Non Current Assets Total are fairly stable compared to the past year. Non Currrent Assets Other is likely to rise to about 12.2 M in 2024, whereas Total Assets are likely to drop slightly above 224.3 M in 2024.Similar Executives
| Showing other executives | INSIDER Age | ||
| BA Chemistry | Orthofix Medical | 63 | |
| Ed Joyce | Axogen Inc | N/A | |
| Heather Whalen | ProSomnus Common Stock | N/A | |
| Alan Connaughton | LENSAR Inc | 52 | |
| Jerry Vogel | ProSomnus Common Stock | N/A | |
| John Esq | Ainos Inc | 57 | |
| Lauren Cristina | PulmonxCorp | N/A | |
| Ilya Goldshleger | Rxsight | 49 | |
| Kendra Wong | LENSAR Inc | 44 | |
| Mindy Hungerman | ProSomnus Common Stock | N/A | |
| Len Liptak | ProSomnus Common Stock | N/A | |
| Matt Haller | Rxsight | N/A | |
| Ehab Esmail | Orthofix Medical | 52 | |
| Derrick Sung | PulmonxCorp | 51 | |
| Eric Weinberg | Rxsight | 63 | |
| Gregory Davault | Axogen Inc | 56 | |
| Geoffrey Rose | PulmonxCorp | 50 | |
| Fuad Ahmad | IRIDEX | 54 | |
| Sung Kim | ProSomnus Common Stock | 42 | |
| Steve Everly | Rxsight | N/A | |
| Daniel Owens | Treace Medical Concepts | 52 | |
Management Performance
| Return On Equity | 0.0955 | ||||
| Return On Asset | -0.12 |
Anterix Leadership Team
Elected by the shareholders, the Anterix's board of directors comprises two types of representatives: Anterix inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Anterix. The board's role is to monitor Anterix's management team and ensure that shareholders' interests are well served. Anterix's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Anterix's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Richard Creegan, Vice Sales | ||
| Carlos LAbbate, Chief Officer | ||
| Gretchen Starcher, Chief Officer | ||
| Christopher GuttmanMcCabe, Chief Officer | ||
| Deanne Campbell, Chief Staff | ||
| Timothy Gray, Chief Officer | ||
| Natasha Vecchiarelli, Vice Communications | ||
| Robert Schwartz, CEO President | ||
| Ryan Gerbrandt, Chief Officer | ||
| Gena Ashe, Chief Secretary | ||
| Alice Gonzalez, Senior Development | ||
| Rafael Sulit, Vice Marketing | ||
| Morgan OBrien, Executive Chairman |
Anterix Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Anterix a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0955 | ||||
| Return On Asset | -0.12 | ||||
| Profit Margin | 4.47 % | ||||
| Operating Margin | (10.07) % | ||||
| Current Valuation | 529.15 M | ||||
| Shares Outstanding | 18.52 M | ||||
| Shares Owned By Insiders | 2.84 % | ||||
| Shares Owned By Institutions | 88.22 % | ||||
| Number Of Shares Shorted | 1.02 M | ||||
| Price To Earning | (31.65) X |
Pair Trading with Anterix
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Anterix position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anterix will appreciate offsetting losses from the drop in the long position's value.Moving against Anterix Stock
| 0.61 | SJ | Scienjoy Holding Corp Report 26th of April 2024 | PairCorr |
| 0.49 | IRDM | Iridium Communications Buyout Trend | PairCorr |
| 0.43 | DLPN | Dolphin Entertainment | PairCorr |
The ability to find closely correlated positions to Anterix could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Anterix when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Anterix - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Anterix to buy it.
The correlation of Anterix is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Anterix moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Anterix moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Anterix can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anterix. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. For more information on how to buy Anterix Stock please use our How to Invest in Anterix guide.Note that the Anterix information on this page should be used as a complementary analysis to other Anterix's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Complementary Tools for Anterix Stock analysis
When running Anterix's price analysis, check to measure Anterix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anterix is operating at the current time. Most of Anterix's value examination focuses on studying past and present price action to predict the probability of Anterix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anterix's price. Additionally, you may evaluate how the addition of Anterix to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |
Is Anterix's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anterix. If investors know Anterix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anterix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.83 | Revenue Per Share 0.188 | Quarterly Revenue Growth 1.199 | Return On Assets (0.12) | Return On Equity 0.0955 |
The market value of Anterix is measured differently than its book value, which is the value of Anterix that is recorded on the company's balance sheet. Investors also form their own opinion of Anterix's value that differs from its market value or its book value, called intrinsic value, which is Anterix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anterix's market value can be influenced by many factors that don't directly affect Anterix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Anterix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Anterix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anterix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.